BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16729307)

  • 1. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
    Li B; Sun R; Wei H; Gao B; Tian Z
    Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.
    Nakashima H; Kinoshita M; Nakashima M; Habu Y; Shono S; Uchida T; Shinomiya N; Seki S
    Hepatology; 2008 Dec; 48(6):1979-88. PubMed ID: 18942689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
    Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
    Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
    Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
    J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice.
    Louis H; Le Moine A; Flamand V; Nagy N; Quertinmont E; Paulart F; Abramowicz D; Le Moine O; Goldman M; Devière J
    Gastroenterology; 2002 Jun; 122(7):2001-10. PubMed ID: 12055605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis.
    Yamanaka A; Hamano S; Miyazaki Y; Ishii K; Takeda A; Mak TW; Himeno K; Yoshimura A; Yoshida H
    J Immunol; 2004 Mar; 172(6):3590-6. PubMed ID: 15004160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction.
    Habu Y; Shinomiya N; Kinoshita M; Matsumoto A; Kawabata T; Seki S
    Clin Exp Med; 2007 Mar; 7(1):30-8. PubMed ID: 17380303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis.
    Zhao N; Hao J; Ni Y; Luo W; Liang R; Cao G; Zhao Y; Wang P; Zhao L; Tian Z; Flavell R; Hong Z; Han J; Yao Z; Wu Z; Yin Z
    J Immunol; 2011 Nov; 187(10):5007-14. PubMed ID: 21987663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
    Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
    Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
    Sun R; Tian Z; Kulkarni S; Gao B
    J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells.
    Biburger M; Tiegs G
    J Immunol; 2005 Aug; 175(3):1540-50. PubMed ID: 16034092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
    Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
    J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periplocoside A, a pregnane glycoside from Periploca sepium Bge, prevents concanavalin A-induced mice hepatitis through inhibiting NKT-derived inflammatory cytokine productions.
    Wan J; Zhu YN; Feng JQ; Chen HJ; Zhang RJ; Ni J; Chen ZH; Hou LF; Liu QF; Zhang J; Yang L; Tang W; Yang YF; Nan FJ; Zhao WM; Zuo JP
    Int Immunopharmacol; 2008 Sep; 8(9):1248-56. PubMed ID: 18602071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes.
    Jaruga B; Hong F; Sun R; Radaeva S; Gao B
    J Immunol; 2003 Sep; 171(6):3233-44. PubMed ID: 12960353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation.
    Ren J; Meng S; Yan B; Yu J; Liu J
    Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid alleviates Con A-induced hepatitis and differentially regulates effector production in NKT cells.
    Lee KA; Song YC; Kim GY; Choi G; Lee YS; Lee JM; Kang CY
    Eur J Immunol; 2012 Jul; 42(7):1685-94. PubMed ID: 22585464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice.
    Volarevic V; Milovanovic M; Ljujic B; Pejnovic N; Arsenijevic N; Nilsson U; Leffler H; Lukic ML
    Hepatology; 2012 Jun; 55(6):1954-64. PubMed ID: 22213244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.
    Gazdic M; Simovic Markovic B; Vucicevic L; Nikolic T; Djonov V; Arsenijevic N; Trajkovic V; Lukic ML; Volarevic V
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e1173-e1185. PubMed ID: 28488390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in mice.
    Goto M; Tanaka Y; Murakawa M; Kadoshima-Yamaoka K; Inoue H; Murafuji H; Nagahira A; Kanki S; Hayashi Y; Nagahira K; Ogata A; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
    Int Immunopharmacol; 2009 Oct; 9(11):1347-51. PubMed ID: 19671449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis.
    Kaneko Y; Harada M; Kawano T; Yamashita M; Shibata Y; Gejyo F; Nakayama T; Taniguchi M
    J Exp Med; 2000 Jan; 191(1):105-14. PubMed ID: 10620609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.